Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
Müjdat Zeybel, Muhammad Arif, Xiangyu Li, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Multi-omic approaches for host-microbiome data integration
Ashwin Chetty, Ran Blekhman
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 21
MAFLD as part of systemic metabolic dysregulation
Jing Zhao, Lu Liu, Yingying Cao, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 834-847
Closed Access | Times Cited: 15
Oral-gut microbial transmission promotes diabetic coronary heart disease
Yiwen Li, Yanfei Liu, Jing Cui, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Genome-scale models in human metabologenomics
Adil Mardinoğlu, Bernhard Ø. Palsson
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 10
Effects of data transformation and model selection on feature importance in microbiome classification data
Zuzanna Karwowska, Oliver Aasmets, Tomasz Kościółek, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease
Emmanouil Nychas, Andrea Marfil-Sánchez, Xiuqiang Chen, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Gut Microbiota Signature of Obese Adults Across Different Classifications
Junqing Hu, Pengsen Guo, Rui Mao, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3933-3947
Open Access | Times Cited: 34
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19
Alessandra Soares‐Schanoski, Natalie Sauerwald, Carl Goforth, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Diet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease
Retu Haikonen, Olli Kärkkäinen, Ville Koistinen, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 7, pp. 463-480
Open Access | Times Cited: 32
Metabolomics and lipidomics strategies in modern drug discovery and development
Giuseppe Astarita, Rachel S. Kelly, Jessica Lasky‐Su
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103751-103751
Open Access | Times Cited: 20
Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine
Jia Wang, Jiayou Luo, Fei Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer’s disease
L. Meng, Han Jin, Burak Yuluğ, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
Qi Zhang, Wenmin Xing, Qiao Wang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 21
Differences in meat quality between Angus cattle and Xinjiang brown cattle in association with gut microbiota and its lipid metabolism
Zhuo Chen, Yawei Sun, Lijing Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 21
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Wesam Bahitham, S. Al-Ghamdi, Ibrahim Omer, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 550-550
Open Access | Times Cited: 4
Dietary Inflammatory index and its association with fatty liver disease: a study in obese and non-obese populations
Wei Fu, Junlong Zhao, Guo Cheng, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Gut dysbiosis associates with cytokine production capacity in viral-suppressed people living with HIV
Yue Zhang, Sergio Andreu‐Sánchez, Nadira Vadaq, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10
Total Sn-2 Palmitic Triacylglycerols and the Ratio of OPL to OPO in Human Milk Fat Substitute Modulated Bile Acid Metabolism and Intestinal Microbiota Composition in Rats
Lin Zhu, Shuaizhen Fang, Hong Zhang, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4929-4929
Open Access | Times Cited: 10
Early‐life antibiotic exposure aggravates hepatic steatosis through enhanced endotoxemia and lipotoxic effects driven by gut Parabacteroides
Xi Zhang, Darren Chan, Jie Zhu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma
Mahmoud Zhra, Muhammad Affan Elahi, Aamira Tariq, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 466-466
Open Access
Gut microbiome composition and metabolic activity in metabolic associated fatty liver disease
Daya Zhang, Qi Wang, Da Li, et al.
Virulence (2025)
Open Access
Gut Microbiota Colonization in Early Life Influences Susceptibility to Adulthood Hepatic Lipid Accumulation in High‐Fat‐Diet‐Fed Mice
Yanyan Zhu, Xin Dong, N. Zhou, et al.
Advanced Science (2025)
Open Access
Identifying the Novel Gut Microbial Metabolite Contributing to Metabolic Syndrome in Children Based on Integrative Analyses of Microbiome-Metabolome Signatures
Jia Wei, Wen Dai, Xiongfeng Pan, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 9
Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
Xi Jia, Erfei Song, Yan Liu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101257-101257
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top